CG Oncology, Inc.
CGON
$19.28
$1.659.36%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -31.80M | -20.41M | -18.90M | -16.93M | -16.56M |
| Total Depreciation and Amortization | 0.00 | 21.00K | 7.00K | 4.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -9.00K |
| Total Other Non-Cash Items | 6.24M | 1.06M | -230.00K | -685.00K | -670.00K |
| Change in Net Operating Assets | 4.90M | 3.40M | 3.01M | -8.40M | 2.59M |
| Cash from Operations | -20.66M | -15.92M | -16.12M | -26.01M | -14.65M |
| Capital Expenditure | -209.00K | 1.00K | -14.00K | -12.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.11M | 32.00M | -36.22M | -307.43M | 15.53M |
| Cash from Investing | 10.91M | 32.01M | -36.23M | -307.44M | 15.53M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -365.00K | -7.00K |
| Issuance of Common Stock | 223.41M | 2.17M | 77.00K | 406.41M | 262.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 410.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -37.00K | -3.39M | -3.56M |
| Cash from Financing | 223.41M | 2.17M | 40.00K | 402.66M | -2.90M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 213.66M | 18.25M | -52.31M | 69.20M | -2.01M |
